Next Article in Journal
Evaluation of Hydroxycarboxylic Acid Receptor 1 (HCAR1) as a Building Block for Genetically Encoded Extracellular Lactate Biosensors
Previous Article in Journal
Compact Surface Plasmon Resonance IgG Sensor Based on H-Shaped Optical Fiber
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Electrochemical Impedance Spectroscopy-Based Aptasensor for the Determination of SARS-CoV-2-RBD Using a Carbon Nanofiber–Gold Nanocomposite Modified Screen-Printed Electrode

by
Mahmoud Amouzadeh Tabrizi
and
Pablo Acedo
*
Electronic Technology Department, Universidad Carlos III de Madrid, 28911 Leganes, Spain
*
Author to whom correspondence should be addressed.
Biosensors 2022, 12(3), 142; https://doi.org/10.3390/bios12030142
Submission received: 20 January 2022 / Revised: 23 February 2022 / Accepted: 24 February 2022 / Published: 25 February 2022
(This article belongs to the Section Biosensor and Bioelectronic Devices)

Abstract

:
Worldwide, human health is affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, the fabrication of the biosensors to diagnose SARS-CoV-2 is critical. In this paper, we report an electrochemical impedance spectroscopy (EIS)-based aptasensor for the determination of the SARS-CoV-2 receptor-binding domain (SARS-CoV-2-RBD). For this purpose, the carbon nanofibers (CNFs) were first decorated with gold nanoparticles (AuNPs). Then, the surface of the carbon-based screen-printed electrode (CSPE) was modified with the CNF–AuNP nanocomposite (CSPE/CNF–AuNP). After that, the thiol-terminal aptamer probe was immobilized on the surface of the CSPE/CNF–AuNP. The surface coverage of the aptamer was calculated to be 52.8 pmol·cm−2. The CSPE/CNF–AuNP/Aptamer was then used for the measurement of SARS-CoV-2-RBD by using the EIS method. The obtained results indicate that the signal had a linear–logarithmic relationship in the range of 0.01–64 nM with a limit of detection of 7.0 pM. The proposed aptasensor had a good selectivity to SARS-CoV-2-RBD in the presence of human serum albumin; human immunoglobulins G, A, and M, hemagglutinin, and neuraminidase. The analytical performance of the aptasensor was studied in human saliva samples. The present study indicates a practical application of the CSPE/CNF-AuNP/Aptamer for the determination of SARS-CoV-2-RBD in human saliva samples with high sensitivity and accuracy.

1. Introduction

Coronavirus disease2019 (COVID-19) as an ongoing global infectious disease outbreak has caused a catastrophic impact on the world economy and healthcare systems. For this reason, there is a growing interest in the fabrication of a highly selective and sensitive device to diagnose the related virus that is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By now, several methods have been reported for the sensitive detection of the SARS-CoV-2 in the literature, such as gene-based [1,2], immune-based [3,4] aptamer-based [5,6], and molecularly imprinted polymer-based assays [7,8]. The gene-based method is the most widely used [6,9,10]. In the gene-based method, the nucleotide chain of the SARS-CoV-2 must be first extracted and then detected. Although this method has very high sensitivity, it suffers from several drawbacks, such as being time-consuming, expensive (for a point-of-care device), and needing an operator with a high level of experience.
The immune-based method is performed in two different cases. In the first case, the ACE-2 antibody is immobilized on the surface of a transducer to detect the spike protein of the SARS-CoV-2 [4,11,12,13,14,15]. In the second case, the antigen is immobilized on the surface of a substrate (antigen sorbent assay) to detect antibody levels [16].
In the aptamer-based method, an aptamer is used to detect SARS-CoV-2-related proteins, such as the receptor-binding domain (RBD) [17,18], spike protein [19,20], and the nucleocapsid protein (Np) [21,22,23].
Aptamer-based assay methods have several advantages over immune-based and gene-based assays, such as being low cost, having high stability, being easy to modify, and, in some cases, it has better specificity and affinity [24].
In addition, electrochemical methods have several advantages, such as being low cost, having high sensitivity, their ease of use and operation, and having the potential to be integrated with point-of-care devices [25,26,27,28,29]. Among them, electrochemical impedance spectroscopy has a good potential to detect SARS-CoV-2 [30,31,32,33,34].
For these reasons, in this paper, we design an electrochemical impedance spectroscopy-based aptasensor to detect the SARS-CoV-2-RBD. To this end, a carbon nanofiber–gold nanoparticle (CNF–AuNP) nanocomposite is used as a modifier. The CNF–AuNP nanocomposite has several advantages, such as having high conductivity, high surface area, biocompatibility, high electrochemical and thermal stability [35], and being able to interact with thiol-terminal bio-recognizers, such as aptamers. To take advantage of this, the thiol-terminal aptamer is used for the fabrication of the aptasensor. After the modification of the carbon screen-printed electrode (CSPE) with CNFs-AuNPS, the thiol-terminal aptamer probes were immobilized on the surface of the CSPE/CNFs-AuNPs via an Au–S covalent bond. The obtained results show that the fabricated aptasensor has a high affinity and sensitivity to the SARS-CoV-2-RBD compared to previous aptasensors [17,18]. Additionally, the fabricated aptasensor showed high selectivity and stability. The results proved the practical application of the CSPE/CNFs-AuNPs in human saliva samples.

2. Materials and Methods

2.1. Reagents and Chemicals

All chemicals were of analytical reagent grade and used without further purification. Double deionized (DI) water (18.6 MΩ) was used throughout the research work. The thiol terminal aptamer was purchased from Nzytech (Lisboa, Portugal) with a sequence SH-(CH2)6−CAG CAC CGA CCT TGT GCT TTG GGA GTG CTG GTC CAA GGG CGT TAA TGG ACA-3′ [14]. Syndrome coronavirus-2 receptor-binding domain (SARS-CoV-2-RBD), human serum albumin (HSA), human immunoglobulin A (HIgA), human immunoglobulin M (HIgM), human immunoglobulin G (HIgG), hemagglutinin (HA), neuraminidase (N), sodium tetrachloroaurate (NaAuCl4), sodium borohydride (NaBH4), phosphoric acid (H3PO4), potassium hydroxide (KOH), potassium ferricyanide (K3Fe(CN)6), potassium ferrocyanide (K4Fe(CN)6), chitosan, and hexaammineruthenium (III) chloride ([Ru(NH3)6]Cl3) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Dual working screen-printed electrodes (Ref X1110) were obtained from Metrohm-Drop Sens (Llanera, Spain).

2.2. Apparatus

The surface morphologies of the electrodes were characterized using scanning electron microscopy (SEM) (Field Electron and Ion (FEI)) (FEI, Hillsboro, OR, USA.). The cyclic voltammetry (CV) studies were performed using a potentiostat from Metrohm-DropSens Model µStat300 (Llanera, Spain). The elemental analysis was performed using an energy dispersive analysis of X-rays (EDX) (EDAX, Mahwah, NJ, USA). The attenuated total reflectance spectrum (ATR) study was performed by using a Nicolet iS50 Fourier transform infrared spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Electrochemical impedance spectroscopy (EIS) experiments were carried out using an ISX-3 impedance analyzer (Sciospec, Bennewitz, Germany) in phosphate-buffered saline (0.1 M PBS, pH 7.4) containing 5.0 mM Fe(CN)64−/3− couple (1:1) as the redox probe. An alternating current (AC) voltage of 10 mV and direct current (DC) voltage of 0.13 V were applied over a frequency range of 100 kHz to 0.1 Hz and the output signal was acquired using an EIS spectrum analyzer (EISSA) software.

2.3. Fabrication of the CSPE/CNF-AuNP/Aptamer

A total of 100 µL of NaAuCl4 (0.01 mM) were added into 9.8 mL of CNFs solution (0.025 g) and then mixed by ultrasonication for 60 min. After that, 100 µL of NaBH4 (0.01 mM) was added to the previous solution and mixed for another 60 min by ultrasonication. Then, CNFs–AuNPs were separated and dried. The fabricated CNF–AuNP nanocomposite was dispersed in a 10 mL chitosan (0.5%, acetate buffer pH 5.4) solution. The surface of the CSPE was then modified with 4 µL of the CNFs–AuNPs (12 µg, 0.1 M sodium acetate, pH 7.4) by the drop-casting technique and allowed to dry at room temperature. After that, the CSPE/CNFs–AuNPs was washed with DI water. Subsequently, 150 µL of thiol-terminal aptamer (120 nmol, 1 mM Mg2+, 0.1 M sodium acetate, pH 7.4) was dropped on the surface of the CSPE/CNFs–AuNPs for 24 h. During this time, the thiol-terminal aptamer probes interacted with AuNPs via the S–Au covalent bonds [36]. The CSPE/CNF–AuNP/Aptamer was then washed with 0.1 M PBS to remove loosely adsorbed aptamer. The CSPE/CNF–AuNP/Aptamer was immersed in 2% BSA solution (0.1M PBS, pH 7.4) for 60 min at room temperature to block nonspecific sites. The CSPE/CNF–AuNP/Aptamer was finally washed with DI water and stored in the refrigerator when not in use. Figure S1 shows the schematic illustration of the CSPE/CNF–AuNP/Aptamer fabrication and sensing process.

2.4. Measurement Procedure of SARS-CoV-2-RBD in PBS

The typical EIS in the form of the Nyquist plot was used for the measurement of the SARS-CoV-2-RBD concentration in the measuring buffer (5 mM Fe(CN)63−/4−, 0.1 M PBS, pH 7.4).
During the measurement process, the CSPE/CNF–AuNP/Aptamer was first immersed in a PBS (0.1 M, pH 7.4) for 40 min at room temperature to record the blank signal. Then, the aptasensor was washed with a PBS (0.1 M, washing buffer) and then immersed in the measuring buffer to record the EIS signal. After that, the CSPE/CNF–AuNP/Aptamer was immersed in a PBS (0.1 M, pH 7.4) containing different concentrations of SARS-CoV-2-RBD for 40 min at room temperature. During this period, the SARS-CoV-2-RBD was incubated with aptamer probes. After that, the aptasensor was rinsed with washing buffer to wash away any loosely adsorbed SARS-CoV-2-RBD. The aptasensor was then immersed in the measuring buffer to record the EIS signal. In this way, as the SARS-CoV-2-RBD is a big molecule (35 kDa), the Rct of the aptasensor will increase every time that aptasensor incubates with SARS-CoV-2-RBD. The standard deviation (SD) of the error bars for the ΔRct measurement were obtained by using four different aptasensors for a fixed concentration of SARS-CoV-2-RBD.

2.5. Data Processing and Statistical Analysis

The semicircle diameter in the impedance spectrum equals the charge-transfer resistance (Rct). The Rct is related to the charge transfer kinetics of the redox probe at the interface of the electrode. During the measurement process, the change in the Rct of the aptasensor in the absence (blank) and the presence of a fixed concentration of SARS-CoV-2-RBD (ΔRct) was recorded as the response of the CSPE/CNF–AuNP/Aptamer to the SARS-CoV-2-RBD in a solution. The EISSA software was used to analyze the Nyquist plots and obtain the ΔRct values for all the EIS measurements. To calculate the standard error bars, first, the SD of ΔRct from four different aptasensors was calculated. The calculated value was then divided by two (the square root of four measurements for the fixed concentration of SARS-CoV-2-RBD). So, the standard error bars were calculated with Equation (1):
Error   bar = SD   of   the   Δ R ct   / n   ( n = 4 )
Additionally, the relative standard deviation (RSD) was calculated by dividing the SD of ΔRct values by the mean values of the ΔRct Equation (2):
RSD = SD of ΔRct /Mean of ΔRct
The limit of detection (LOD) was calculated by dividing the SD of the absolute value of Rct related to the blank measurements (zero concentration of SARS-CoV-2-RBD) of four different aptasensors (σ) by the slope of the calibration curve (S). So, the detection limit was calculated with Equation (3):
LOD = 3σ/S
The value was then multiplied by three. All the statistical analysis were performed according to the literature [37].

2.6. Measurement Procedurein a Real Sample in Absence of SARS-CoV-2-RBD

First, the CSPE/CNF–AuNP/Aptamer was immersed in a PBS solution for 40 min and then washed. Subsequently, the EIS of the electrode was recorded in the measuring buffer (Figure S5A, blue curve). The CSPE/CNF–AuNP/Aptamer was then immersed in 50 µL of 0.2 M PBS containing 50 µL of normal human saliva for 40 min at room temperature. After that, the aptasensor was washed with the washing buffer and then the EIS of the aptasensor was recorded in the measuring buffer. The PBS was added to the saliva sample to change its pH to 7.4 (the optimum pH) and increase its ionic conductivity (ionic conductance) for the electrochemical measurement.

2.7. Measurement Procedurein Real Sample in Presence of SARS-CoV-2-RBD

In this process, two different concentrations of SARS-CoV-2-RBD were spiked in the saliva sample to measure them. To this end, 2 mL of normal human saliva sample was diluted with 1.8 mL PBS (0.1 M, pH 7.4). Then, the solution was mixed and divided into two vial samples. A total of 0.1 mL of 2.0 nMSARS-CoV-2-RBD solution was then added to the first vial and 0.1 mL of 16 nM SARS-CoV-2-RBD was added into the second vial. The samples were mixed for 30 min. After that, an aptasensor was immersed in the first vial (1.0 nMSARS-CoV-2-RBD) and another aptasensor was immersed in the second vial (8.0 nM SARS-CoV-2-RBD), each one for 40 min at room temperature. The aptasensors were then taken out and washed with 0.1 M PBS (pH 7.4). Finally, the aptasensors were dipped in the measuring buffer to record the EIS (Figure S5B).

3. Results

3.1. The Surface Characterization of the Electrodes

The SEM images of a CSPE (A, B) and a CSPE/CNFs–AuNPs (C–F) are shown in Figure 1. As can be seen, the surface morphology of the CSPE before and after modification with CNFs–AuNPs changed. The presence of the AuNPs allows the thiol-terminal aptamers to be immobilized on the surface of the electrode. The average diameter of the CNFs and AuNPs was 101 nm and 10.1 nm, respectively.
Elemental analyses of CSPE/CNFs–AuNPs (a) and CSPE/CNF–AuNP/Aptamer (b) were also carried out by EDX technique (Figure 2A). The EDX spectrum of a CSPE/CNFs–AuNPs shows the presence of the gold element (Figure 2(Aa)). It indicates that the surface of the CSPE was properly modified with CNFs–AuNPs. After the immobilization of the thiol terminal aptamers, nitrogen, phosphor, and sulfur elements appeared in the EDX spectrum of the electrode (Figure 2(Ab)), indicating that the thiol-terminal aptamers were immobilized on the surface of the electrode.
The ATR spectrum of a CSPE/CNF–AuNP/Aptamer is also shown in Figure 2B. An absorption band at 3013 cm−1 due to the –NH2 stretching was observed. Additionally, an absorption band at 2622 cm−1 due to –CH stretching, an absorption band at 1609 cm−1 due to –C=C stretching, an absorption band at 1480 cm−1 due to in-plane vibration of nucleotide bases, an absorption band at 1333 cm−1 due to the –C–N stretching of nucleotide bases, an absorption band at 1221 cm−1 due to the –PO2 stretching, an absorption band at 1163 cm−1 due to the –C–O stretching of aliphatic ether in deoxyribose, an absorption band at 965 cm−1 due to PO2 bending, an absorption band at 890 cm−1 due to the deoxyribose ring vibration, and an absorption band at 710 cm−1 due to sugar-phosphate vibration are clearly seen [38]. The ATR results indicated that the aptamer probes were immobilized on the surface of the electrode.

3.2. Electrochemical Activity of the Modified Electrode

The electroactive surface area (Aeas) and the roughness factor (RF) of the CSPE and the CSPE/CNF–AuNP were also obtained in a 5 mM Fe(CN)64−/3− solution (0.1 M PBS, pH 7.4) as the redox probe. The results show that the CNFs–AuNPs increase the electroactive surface area (Aeas) of the electrode from 0.049 to 0.24 cm−2, the roughness factor (RF) of the electrode from 0.78 to 4.0, and the heterogeneous electron transfer constant (k0) of the probe from 0.004 cm·s−1 to 0.11 cm·s−1. It indicates that the CNFs–AuNPs nanocomposite significantly improved the electrochemical parameters of the electrode. More details are included in the supplementary section (Figure S2).

3.3. Study the Surface Coverage of the Immobilized Aptamer

The surface coverage of the aptamer (Γaptamer)on the surface of the electrode was obtained according to the electrostatic interaction between Ru(NH3)63+ as a positively charged redox probe and the negatively charged phosphate backbone of aptamer [39]. The surface coverage of the aptamer (Γaptamer) was found to be 52.8 pmol·cm−2 (3.18 × 1013 molecules·cm−2). The relevant discussions and figures are given in the electronic supporting material (Figure S3).

3.4. Electrochemical Characterization of the CSPE/CNF–AuNP/Aptamer

The step-by-step electrochemical characterizations of the aptasensor were performed by EIS (Figure 3A) and CV (Figure 3B) in a 0.1 M PBS (pH 7.4) containing 5 mM Fe(CN)64−/3− as the redox probe. Figure 3A shows the EIS of the CSPE (a), the CSPE/CNFs–AuNPs (b), the CSPE/CNF–AuNP/Aptamer (c), and the CSPE/CNF–AuNP/Aptamer/SARS-CoV-2-RBD (d). As it can be seen in Figure 3A, after the modification of the CSPE (a) with CNFs–AuNPs (b), the diameter of the semicircular portion of the graph that is related to the Rct decreased from 3048 Ω to 135.7 Ω, indicating that CNFs–AuNPs facilitated the charge transfer rate of the redox probe to the surface of the electrode. However, after the immobilization of the aptamer, the Rct increased to 1186.6 Ω due to the electrostatic repulsion interaction between the negatively charged aptamer and the negatively charged electrochemical probe (Fe(CN)64−/3−). This repulsion interaction hindered the electron transfer of the electrochemical probe to the surface of the electrode and, consequently, the Rct increased. After the incubation of the SARS-CoV-2-RBD (64 nM) with the immobilized aptamer (d), the Rct increased to 2432 Ω due to the mass-transfer limiting of Fe(CN)63−/4− to the electrode surface that is caused by a big molecule, such as SARS-CoV-2-RBD (~35 kDa) [13]. The details of the EIS spectrum are given in Table S1 of the supporting material.
Additionally, CVs (Figure 3B) studies showed that the intensity of the anodic and cathodic peaks increased after the modification of the CSPE (a) with CNFs–AuNPs (b). In addition, the difference between the potential of the anodic peak and the cathodic peak (ΔE=Epa − Epc) decreased. As the aptamer probes were immobilized on the surface of the CSPE/CNFs–AuNPs (c), the intensity of these peaks decreased and the ΔE of them increased. After the incubation of the SARS-CoV-2-RBD with the immobilized aptamer probes (d), the intensity of the peaks and their ΔE decreased and increased more than before, respectively. All these changes in the EIS and CV characterizations of the electrode indicate that the electron transfer property of the CSPE was changed after each modification step.

3.5. Optimization of the Effective Parameters on the Response of the CSPE/CNF–AuNP/Aptamer

The effects of the amount of the immobilized aptamer, the incubation time, and pH of the solution during the incubation on the response of the CSPE/CNF–AuNP/Aptamer to 5.0 nM of SARS-CoV-2-RBD (pH 7.4) were investigated in the measuring buffer (Figure S4). The following experimental conditions were found to give the best results: (a) 120 nmol of aptamer probe, (b) incubation time of 40 min, and (c) pH of 7.4 the solution. The relevant discussions and figures are provided in the supporting material.

3.6. Analytical Performance

Figure 4 shows the EIS (A) as well as the linear (B) and logarithmic corresponding calibration plot response (C) of the CSPE/CNF–AuNP/Aptamer to the different concentrations of SARS-CoV-2-RBD in the measuring buffer, respectively. As shown in Figure 4A, the Rct of the biosensor increased as the concentration of SARS-CoV-2-RBD increased. The corresponding calibration plot shows that the response of the proposed biosensor had a logarithmic relationship with the concentration of SARS-CoV-2-RBD in the range of 0.01–64.0 nM (Figure 4B). The linear–logarithmic regression equation of the calibration curve (Figure 4C) is expressed as Equation (4):
ΔRct (kΩ) = 0.313Log C[SARS-CoV-2-RBD] (nM) + 1.8
The LOD of the CSPE/CNF–AuNP/Aptamer was found to be 7.0 pM.
According to the literature, there are between 25 and40 spike proteins on the surface of a SARS-CoV-2 molecule [40]. Since each spike protein of SARS-CoV-2 has an RBD, therefore, the LOD of the CSPE/CNFs-AuNPs/Aptamer would be 1.05–1.69 × 105 copies/µL using Equation (5):
Copies   of   virus / L = Molarity   of   SARS CoV 2 RBD   Number   of   RBD   in   a   Virus × Avogadro s   number
The Langmuir-typical adsorption system (Equation (6)) [41,42] was used to calculate the Langmuir isotherm constant (KL), dissociation constant (Kd), and the maximum number of binding sites (Rctmax) for the CSPE/CNF–AuNP/Aptamer (Figure 4D):
C   SARS CoV 2 RBD Rct = 1 KL × Rct   max + C   SARS CoV 2 RBD Rct   max
where Ret is the steady-state signal after the addition of a biomarker.
The values of 1/Rct max and 1/KL × Rctmax can be obtained from the slope and the intercept point of Figure 4D, respectively. The values of Rct max, KL, and Kd (1/KL) were found to be 2450 µA, 2.35 nM−1, and 0.42nM, respectively. The value of Kd is lower than the previously reported [17,18], indicating that the CSPE/CNF–AuNP/Aptamer has a high affinity to SARS-CoV-2-RBD.
Additionally, the Gibbs free energy of desorption bind for the SARS-CoV-2-RBD-Aptamer was found to be −53.4 kJ·mol−1 by using Equation (7) [43]:
ΔG = 2.03 × R × T × log (Kd)
where R is the universal gas constant of 8.31 J·K−1·mol−1 and T is the temperature in Kelvin.
The analytical performances of the proposed aptasensor were compared with the other reported aptasensors for measuring the biomarkers related to SARS-CoV-2 (Table 1). As can be seen, the analytical performances of the proposed aptasensor are better than the others in most cases. Although the LOD of the gold electrode/Aptamer that was combined with a secondary labeled aptamer for SARS-CoV-2 nucleocapsid protein (2019-nCoV-NP) is lower than the proposed aptasensor for the SARS-CoV-2-RBD [23], however, the process of the measurement of 2019-nCoV-NP was more complicated, expensive, and time-consuming.

3.7. Stability, Reproducibility, and Selectivity of the CSPE/CNFs-AuNPs/Aptamer

The selectivity of the CSPE/CNF–AuNP/Aptamer to 2 nM SARS-CoV-2-RBD was studied in the absence and presence of HIgG, HIgA, HIgM, and HSA (Figure 5A). No sensible interference was observed for 102-fold quantities of biomarkers in the determination of 2.0 nM SARS-CoV-2-RBD. The effect of the possible interference of HA and N from an influenza A virus was also studied (Figure 5B). As it can be seen, the Rct of the CSPE/CNF–AuNP/Aptamer to 2 nM SARS-CoV-2-RBD in the presence of 50 nMHA and neuraminidase N did not change significantly (ΔRct = 16 Ω, or 0.8%).
The stability of the CSPE/CNF–AuNP/Aptamer was also evaluated (Figure 5C). After 14 days, no obvious change was observed in the EIS of the aptasensor to 2.0 nM.
The reproducibility of the CSPE/CNF–AuNP/Aptamer was also evaluated for the measurement of 2.0 nM of SARS-CoV-2-RBD with six different aptasensors. The relative standard deviation (RSD) was calculated to be 3.6%.

3.8. Analytical Application of the Modified Electrode

The EIS of the CSPE/CNF–AuNP/Aptamer was recorded in a human saliva sample to study the possibility of the interference effect of the biomarkers that exist in the human saliva sample (Figure S5A). As it can be seen, the Rct of the electrode did not change, indicating the biomaterials in the saliva sample did not affect the electrochemical properties of the aptasensor.
The CSPE/CNF–AuNP/Aptamer was then used for the measurement of SARS-CoV-2-RBD in human saliva samples to consider its applicability. Figure S5B shows the EIS of the aptasensor to 1 nM and 8 nM of SARS-CoV-2-RBD in human saliva samples. The recovery of the analysis was obtained to be 95.3% and 96.2% for samples 1 and 2, respectively. The SARS-CoV-2 RBD concentrations in the normal human saliva samples were estimated using Figure 4C. The results indicate that the CSPE/CNF–AuNP/Aptamer has a good potential to detect the SARS-CoV-2-RBD in the human saliva samples accurately. The results were considered in comparison with a fluorescence-based assay of SARS-CoV-2-RBD [17].

4. Conclusions

In this paper, a CNF–AuNP nanocomposite was used as a modifier to design an electrochemical aptasensor to detect the SARS-CoV-2-RBD. The CNF–AuNP nanocomposite not only improved the electrochemical parameters of the CSPE but also assisted in the immobilization of the thiol-terminal aptamer probes via gold–thiol covalent bonds. The responses of the aptasensor to different concentrations of SARS-CoV-2-RBD were recorded using the EIS method in the Fe(CN)64−/3− solution as a redox probe. As the SARS-CoV-2-RBD interacted with the aptasensor, the Rct of the aptasensor increased. Hence, the proposed method is a signal-on-based measurement method. The proposed aptasensor showed very good analytical performances in terms of selectivity, sensitivity, excellent repeatability, and satisfactory long-term storage stability. Notably, the affinity of the proposed aptasensor to SARS-CoV-2-RBD was better than the previously reported aptasensors. Lastly, the aptasensor was able to detect SARS-CoV-2-RBD in a human saliva sample. Although the prepared aptasensor paves the way for the design of a tool for the diagnosis of SARS-CoV-2-RBD in a saliva sample, however, it has some disadvantages. First, the sensitivity of the proposed aptasensor is less than that of immunosensors. Second, the use of commercially available electrodes already places the research at a disadvantage in terms of expanding novelty. However, the reproducibility of the signals recorded with the commercially available electrodes is better than that of the non-commercial ones.

Supplementary Materials

The following supporting information [18,45,46,47,48,49,50,51] can be downloaded at: https://www.mdpi.com/article/10.3390/bios12030142/s1, Figure S1. The schematic illustration for the fabrication of the CSPE/CNF–AuNP/Aptamer. Figure S2. (A) CVs of the CSPE and (B) CSPE/CNFs–AuNPs in 5.0 mM Fe(CN)63−/4− solution (0.1M PBS, pH 7.4) at various scan rates (0.01. 0.025, 0.05, 0.075, 0.1, 0.125, and 0.15 V.s−1 from inner to outer). The plot of the anodic peak current (Ipa) and cathodic peak current (Ipc) versus the square root of scan rate (ν½) for (C) CSPE and (D) CSPE/CNFs–AuNPs. Figure S3. (A) CVs of a CSPE/CNF–AuNP/Aptamer before (a) and after (b) the immobilization of Ru(NH3)63+. (B) CVs of the CSPE/CNF–AuNP/Aptamer–Ru(NH3)63+ in a PBS (0.1 M, pH 7.4) at various scan rates (0.01. 0.025, 0.05, 0.075, 0.1, 0.125, 0.15, 0.175, and 0.2 V·s−1 from inner to outer). (C) The plot of the anodic peak current (Ipa) and cathodic peak current versus scan rate (ν). Figure S4. (A) Effect of the aptamer probe concentration, (B) incubation time, and (C) pH on the response of the aptasensor. EIS signals were recorded at 5.0 mM Fe(CN)63−/4− solution (0.1 M PBS, pH 7.4). The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: Charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude was 10 mV, DC potential was 0.13 V, and the frequency range was 100 kHz–0.1 Hz. Figure S5. (A) EIS of the CSPE/CNF–AuNP/Aptamer in the absence (blue curve) and presence of 50 µL of saliva (red curve). (B) EIS of the CSPE/CNF–AuNP/Aptamer to 1 nM SARS-CoV-2 RBD (red curve) and 8 nM SARS-CoV-2 RBD (black curve) that were fabricated in the 2-fold diluted saliva sample. EIS spectrums were recorded in 5.0 mM Fe(CN)63−/4− solution (0.1 M PBS, pH 7.4). The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: Charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude voltage was 10 mV, DC voltage was 0.13 V, and the frequency range was 100 kHz–0.1 Hz.

Author Contributions

Conceptualization: M.A.T.; methodology: M.A.T.; software: M.A.T.; validation: M.A.T.; formal analysis: M.A.T.; investigation: M.A.T.; resources: M.A.T.; data curation: M.A.T.; writing—original draft preparation: M.A.T.; writing—review and editing: M.A.T. and P.A.; visualization: M.A.T.; supervision: M.A.T.; project administration: M.A.T.; funding acquisition: M.A.T. and P.A. All authors have read and agreed to the published version of the manuscript.

Funding

This project received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 801538 and the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación por parte del Ministerio de Ciencia e Innovación, MCIN /AEI /10.13039/501100011033 (Spain), Project PID2020-116439GB-I00 and the Comunidad de Madrid in the framework of the action. “Excelencia para el Profesorado Universitario” inside the V Plan Regional de Investigación Científica e Innovación Tecnológica 2016–2020.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Supplementary data associated with this article can be found in the online version that includes Figures S1–S5 and Table S1.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Song, Z.; Ma, Y.; Chen, M.; Ambrosi, A.; Ding, C.; Luo, X. Electrochemical biosensor with enhanced antifouling capability for COVID-19 nucleic acid detection in complex biological media. Anal. Chem. 2021, 93, 5963–5971. [Google Scholar] [CrossRef] [PubMed]
  2. Soares, J.C.; Soares, A.C.; Rodrigues, V.C.; Oiticica, P.R.A.; Raymundo-Pereira, P.A.; Bott-Neto, J.L.; Buscaglia, L.A.; de Castro, L.D.C.; Ribas, L.C.; Scabini, L.; et al. Detection of a SARS-CoV-2 sequence with genosensors using data analysis based on information visualization and machine learning techniques. Mater. Chem. Front. 2021, 5, 5658–5670. [Google Scholar] [CrossRef]
  3. Li, J.; Lillehoj, P.B. Microfluidic magneto immunosensor for rapid, high sensitivity measurements of SARS-CoV-2 nucleocapsid protein in serum. ACS Sens. 2021, 6, 1270–1278. [Google Scholar] [CrossRef]
  4. Seo, G.; Lee, G.; Kim, M.J.; Baek, S.-H.; Choi, M.; Ku, K.B.; Lee, C.-S.; Jun, S.; Park, D.; Kim, H.G.; et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano 2020, 14, 5135–5142. [Google Scholar] [CrossRef] [Green Version]
  5. Chen, R.; Kan, L.; Duan, F.; He, L.; Wang, M.; Cui, J.; Zhang, Z.; Zhang, Z. Surface plasmon resonance aptasensor based on niobium carbide mxene quantum dots for nucleocapsid of SARS-CoV-2 detection. Mikrochim. Acta 2021, 188, 316. [Google Scholar] [CrossRef] [PubMed]
  6. Divya; Dkhar, D.S.; Kumari, R.; Mahapatra, S.; Kumar, R.; Chandra, P. Ultrasensitive aptasensors for the detection of viruses based on opto-electrochemical readout systems. Biosensors 2022, 12, 81. [Google Scholar] [CrossRef]
  7. Amouzadeh Tabrizi, M.; Fernández-Blázquez, J.P.; Medina, D.M.; Acedo, P. An ultrasensitive molecularly imprinted polymer-based electrochemical sensor for the determination of SARS-CoV-2-rbd by using macroporous gold screen-printed electrode. Biosens. Bioelectron. 2022, 196, 113729. [Google Scholar] [CrossRef]
  8. Ratautaite, V.; Boguzaite, R.; Brazys, E.; Ramanaviciene, A.; Ciplys, E.; Juozapaitis, M.; Slibinskas, R.; Bechelany, M.; Ramanavicius, A. Molecularly imprinted polypyrrole based sensor for the detection of SARS-CoV-2 spike glycoprotein. Electrochim. Acta 2022, 403, 139581. [Google Scholar] [CrossRef]
  9. Qiu, G.; Gai, Z.; Tao, Y.; Schmitt, J.; Kullak-Ublick, G.A.; Wang, J. Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection. ACS Nano 2020, 14, 5268–5277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Alafeef, M.; Dighe, K.; Moitra, P.; Pan, D. Rapid, ultrasensitive, and quantitative detection of SARS-CoV-2 using antisense oligonucleotides directed electrochemical biosensor chip. ACS Nano 2020, 14, 17028–17045. [Google Scholar] [CrossRef]
  11. Fabiani, L.; Saroglia, M.; Galatà, G.; De Santis, R.; Fillo, S.; Luca, V.; Faggioni, G.; D’Amore, N.; Regalbuto, E.; Salvatori, P.; et al. Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva. Biosens. Bioelectron. 2021, 171, 112686. [Google Scholar] [CrossRef] [PubMed]
  12. Mojsoska, B.; Larsen, S.; Olsen, D.A.; Madsen, J.S.; Brandslund, I.; Alatraktchi, F.A. Rapid SARS-CoV-2 detection using electrochemical immunosensor. Sensors 2021, 21, 390. [Google Scholar] [CrossRef] [PubMed]
  13. Mavrikou, S.; Moschopoulou, G.; Tsekouras, V.; Kintzios, S. Development of a portable, ultra-rapid and ultra-sensitive cell-based biosensor for the direct detection of the SARS-CoV-2 s1 spike protein antigen. Sensors 2020, 20, 3121. [Google Scholar] [CrossRef] [PubMed]
  14. Lee, J.-H.; Choi, M.; Jung, Y.; Lee, S.K.; Lee, C.-S.; Kim, J.; Kim, J.; Kim, N.H.; Kim, B.-T.; Kim, H.G. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ace2). Biosens. Bioelectron. 2021, 171, 112715. [Google Scholar] [CrossRef]
  15. Funari, R.; Chu, K.-Y.; Shen, A.Q. Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip. Biosens. Bioelectron. 2020, 169, 112578. [Google Scholar] [CrossRef]
  16. Eissa, S.; Zourob, M. Development of a low-cost cotton-tipped electrochemical immunosensor for the detection of SARS-COV-2. Anal. Chem. 2020, 93, 1826–1833. [Google Scholar] [CrossRef]
  17. Song, Y.; Song, J.; Wei, X.; Huang, M.; Sun, M.; Zhu, L.; Lin, B.; Shen, H.; Zhu, Z.; Yang, C. Discovery of aptamers targeting the receptor-binding domain of the SARS-CoV-2 spike glycoprotein. Anal. Chem. 2020, 92, 9895–9900. [Google Scholar] [CrossRef]
  18. Amouzadeh Tabrizi, M.; Nazari, L.; Acedo, P. A photo-electrochemical aptasensor for the determination of severe acute respiratory syndrome coronavirus 2 receptor-binding domain by using graphitic carbon nitride-cadmium sulfide quantum dots nanocomposite. Sens. Actuators B Chem. 2021, 345, 130377. [Google Scholar] [CrossRef]
  19. Cennamo, N.; Pasquardini, L.; Arcadio, F.; Lunelli, L.; Vanzetti, L.; Carafa, V.; Altucci, L.; Zeni, L. SARS-CoV-2 spike protein detection through a plasmonic d-shaped plastic optical fiber aptasensor. Talanta 2021, 233, 122532. [Google Scholar] [CrossRef]
  20. Lewis, T.; Giroux, E.; Jovic, M.; Martic-Milne, S. Localized surface plasmon resonance aptasensor for selective detection of SARS-CoV-2 s1 protein. Analyst 2021, 146, 7207–7217. [Google Scholar] [CrossRef]
  21. Zhang, L.; Fang, X.; Liu, X.; Ou, H.; Zhang, H.; Wang, J.; Li, Q.; Cheng, H.; Zhang, W.; Luo, Z. Discovery of sandwich type COVID-19 nucleocapsid protein DNA aptamers. Chem. Commun. 2020, 56, 10235–10238. [Google Scholar] [CrossRef] [PubMed]
  22. Liu, R.; He, L.; Hu, Y.; Luo, Z.; Zhang, J. A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers. Chem. Sci. 2020, 11, 12157–12164. [Google Scholar] [CrossRef] [PubMed]
  23. Tian, J.; Liang, Z.; Hu, O.; He, Q.; Sun, D.; Chen, Z. An electrochemical dual-aptamer biosensor based on metal-organic frameworks mil-53 decorated with au@pt nanoparticles and enzymes for detection of COVID-19 nucleocapsid protein. Electrochim. Acta 2021, 387, 138553. [Google Scholar] [CrossRef]
  24. Tabrizi, M.A. Chapter 9—The electrochemical aptasensors for the determination of tumor markers. In Graphene Bioelectronics; Tiwari, A., Ed.; Elsevier: Amsterdam, The Netherlands, 2018; pp. 193–218. [Google Scholar]
  25. Kaya, S.I.; Karadurmus, L.; Ozcelikay, G.; Bakirhan, N.K.; Ozkan, S.A. Electrochemical virus detections with nanobiosensors. In Nanosensors for Smart Cities; Elsevier: Amsterdam, The Netherlands, 2020; pp. 303–326. [Google Scholar]
  26. Layqah, L.A.; Eissa, S. An electrochemical immunosensor for the corona virus associated with the middle east respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes. Microchim. Acta 2019, 186, 224. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Khanmohammadi, A.; Jalili Ghazizadeh, A.; Hashemi, P.; Afkhami, A.; Arduini, F.; Bagheri, H. An overview to electrochemical biosensors and sensors for the detection of environmental contaminants. J. Iran. Chem. Soc. 2020, 17, 2429–2447. [Google Scholar] [CrossRef]
  28. Serafín, V.; Razzino, C.A.; Gamella, M.; Pedrero, M.; Povedano, E.; Montero-Calle, A.; Barderas, R.; Calero, M.; Lobo, A.O.; Yáñez-Sedeño, P.; et al. Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite. Anal. Bioanal. Chem. 2021, 413, 799–811. [Google Scholar] [CrossRef] [PubMed]
  29. Tabrizi, M.A.; Zand, Z. A facile one-step method for the synthesis of reduced graphene oxide nanocomposites by nadh as reducing agent and its application in nadh sensing. Electroanalysis 2014, 26, 171–177. [Google Scholar] [CrossRef]
  30. Rashed, M.Z.; Kopechek, J.A.; Priddy, M.C.; Hamorsky, K.T.; Palmer, K.E.; Mittal, N.; Valdez, J.; Flynn, J.; Williams, S.J. Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector. Biosens. Bioelectron. 2021, 171, 112709. [Google Scholar] [CrossRef]
  31. Abrego-Martinez, J.C.; Jafari, M.; Chergui, S.; Pavel, C.; Che, D.; Siaj, M. Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy. Biosens. Bioelectron. 2021, 195, 113595. [Google Scholar] [CrossRef]
  32. Kiew, L.-V.; Chang, C.-Y.; Huang, S.-Y.; Wang, P.-W.; Heh, C.-H.; Liu, C.-T.; Cheng, C.-H.; Lu, Y.-X.; Chen, Y.-C.; Huang, Y.-X.; et al. Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors. Biosens. Bioelectron. 2021, 183, 113213. [Google Scholar] [CrossRef]
  33. Ehsan, M.A.; Khan, S.A.; Rehman, A. Screen-printed graphene/carbon electrodes on paper substrates as impedance sensors for detection of coronavirus in nasopharyngeal fluid samples. Diagnostics 2021, 11, 1030. [Google Scholar] [CrossRef] [PubMed]
  34. Rahmati, Z.; Roushani, M.; Hosseini, H.; Choobin, H. Electrochemical immunosensor with cu(2)o nanocube coating for detection of SARS-CoV-2 spike protein. Mikrochim. Acta 2021, 188, 105. [Google Scholar] [CrossRef] [PubMed]
  35. Wang, Z.; Wu, S.; Wang, J.; Yu, A.; Wei, G. Carbon nanofiber-based functional nanomaterials for sensor applications. Nanomaterials 2019, 9, 1045. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Tabrizi, M.A.; Shamsipur, M.; Saber, R.; Sarkar, S. Isolation of hl-60 cancer cells from the human serum sample using mno2-pei/ni/au/aptamer as a novel nanomotor and electrochemical determination of thereof by aptamer/gold nanoparticles-poly(3,4-ethylene dioxythiophene) modified gc electrode. Biosens. Bioelectron. 2018, 110, 141–146. [Google Scholar] [CrossRef]
  37. Miller, J.; Miller, J. Statistics and Chemometrics for Analytical Chemistry; Pearson/Prentice Hall: Harlow, UK, 2005. [Google Scholar]
  38. Nowak, E.; Wisła-Świder, A.; Khachatryan, G.; Fiedorowicz, M.; Danel, K. Possible sensor applications of selected DNA–surfactant complexes. Eur.Biophys. J. 2019, 48, 371–381. [Google Scholar] [CrossRef] [Green Version]
  39. Hashkavayi, A.B.; Raoof, J.B.; Park, K.S. Sensitive electrochemical detection of tryptophan using a hemin/g-quadruplex aptasensor. Chemosensors 2020, 8, 100. [Google Scholar] [CrossRef]
  40. Highfield, R. 2020. Available online: https://www.Sciencemuseumgroup.Org.Uk/blog/coronavirus-the-spike/ (accessed on 25 November 2020).
  41. Schwartz, M.P.; Alvarez, S.D.; Sailor, M.J. Porous sio2 interferometric biosensor for quantitative determination of protein interactions:  Binding of protein a to immunoglobulins derived from different species. Anal. Chem. 2007, 79, 327–334. [Google Scholar] [CrossRef] [Green Version]
  42. Kumeria, T.; Santos, A.; Losic, D. Ultrasensitive nanoporous interferometric sensor for label-free detection of gold(iii) ions. ACS Appl. Mater. Interfaces 2013, 5, 11783–11790. [Google Scholar] [CrossRef]
  43. Borea, P.A.; Varani, K.; Gessi, S.; Gilli, P.; Dalpiaz, A. Receptor binding thermodynamics as a tool for linking drug efficacy and affinity. Farmaco 1998, 53, 249–254. [Google Scholar] [CrossRef]
  44. Yakoh, A.; Pimpitak, U.; Rengpipat, S.; Hirankarn, N.; Chailapakul, O.; Chaiyo, S. Paper-based electrochemical biosensor for diagnosing COVID-19: Detection of SARS-CoV-2 antibodies and antigen. Biosens. Bioelectron. 2021, 176, 112912. [Google Scholar] [CrossRef]
  45. García-Miranda Ferrari, A.; Foster, C.W.; Kelly, P.J.; Brownson, D.A.C.; Banks, C.E. Determination of the electrochemical area of screen-printed electrochemical sensing platforms. Biosensors 2018, 8, 53. [Google Scholar] [CrossRef] [Green Version]
  46. Festinger, N.; Morawska, K.; Ivanovski, V.; Ziąbka, M.; Jedlińska, K.; Ciesielski, W.; Smarzewska, S. Comparative electroanalytical studies of graphite flake and multilayer graphene paste electrodes. Sensors 2020, 20, 1684. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Nicholson, R.S. Theory and application of cyclic voltammetry for measurement of electrode reaction kinetics. Anal. Chem. 1965, 37, 1351–1355. [Google Scholar] [CrossRef]
  48. Lavagnini, I.; Antiochia, R.; Magno, F. An extended method for the practical evaluation of the standard rate constant from cyclic voltammetric data. Electroanalysis 2004, 16, 505–506. [Google Scholar] [CrossRef]
  49. Rafiee-Pour, H.-A.; Behpour, M.; Keshavarz, M. A novel label-free electrochemical mirna biosensor using methylene blue as redox indicator: Application to breast cancer biomarker mirna-21. Biosens. Bioelectron. 2016, 77, 202–207. [Google Scholar] [CrossRef]
  50. Steel, A.B.; Herne, T.M.; Tarlov, M.J. Electrochemical quantitation of DNA immobilized on gold. Anal. Chem. 1998, 70, 4670–4677. [Google Scholar] [CrossRef] [PubMed]
  51. Laviron, E. General expression of the linear potential sweep voltammogram in the case of diffusionless electrochemical systems. J. Electroanal. Chem. Interf. Electrochem. 1979, 101, 19–28. [Google Scholar] [CrossRef]
Figure 1. (A,B) SEM images of the CSPE and (CF) CSPE/CNFs–AuNPs.
Figure 1. (A,B) SEM images of the CSPE and (CF) CSPE/CNFs–AuNPs.
Biosensors 12 00142 g001
Figure 2. (A) EDS of the CSPE/CNFs–AuNPs (a) and the CSPE/CNF–AuNP/Aptamer (b). (B) ATR spectrum of the CSPE/CNF–AuNP/Aptamer.
Figure 2. (A) EDS of the CSPE/CNFs–AuNPs (a) and the CSPE/CNF–AuNP/Aptamer (b). (B) ATR spectrum of the CSPE/CNF–AuNP/Aptamer.
Biosensors 12 00142 g002
Figure 3. (A) EIS and (B) CVs and of the CSPE (a) the CSPE/CNFs–AuNPs (b), the CSPE/CNF–AuNP/Aptamer (c), and the CSPE/CNF–AuNP/Aptamer/SARS-CoV-2-RBD (d) at 0.1 M 5.0 mM Fe(CN)63−/4− solution (0.1 M PBS, pH 7.4). The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude voltage was 10 mV, DC voltage was 0.13 V, and frequency range was 100 kHz−0.1 Hz. The solid black lines indicate fitting curves. CVs were recorded at the scan rate of 0.05 V·s−1.
Figure 3. (A) EIS and (B) CVs and of the CSPE (a) the CSPE/CNFs–AuNPs (b), the CSPE/CNF–AuNP/Aptamer (c), and the CSPE/CNF–AuNP/Aptamer/SARS-CoV-2-RBD (d) at 0.1 M 5.0 mM Fe(CN)63−/4− solution (0.1 M PBS, pH 7.4). The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude voltage was 10 mV, DC voltage was 0.13 V, and frequency range was 100 kHz−0.1 Hz. The solid black lines indicate fitting curves. CVs were recorded at the scan rate of 0.05 V·s−1.
Biosensors 12 00142 g003
Figure 4. (A) The EIS of the CSPE/CNF–AuNP/Aptamer at the optimum operating conditions for different concentration of SARS-CoV-2-RBD (0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1.0, 2, 4, 8, 16, 32, and 64 nM) at 5.0 mM Fe(CN)63−/4− solution (0.1 M PBS, pH 7.4). (B) The linear-linear and (C) linear-logarithmic calibration curve plots. (D) The plot of the Langmuir binding isotherm model. The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude voltage was 10 mV, DC voltage was 0.13 V, and the frequency range was 100 kHz–0.1 Hz. The error bars were obtained by using four different aptasensors.
Figure 4. (A) The EIS of the CSPE/CNF–AuNP/Aptamer at the optimum operating conditions for different concentration of SARS-CoV-2-RBD (0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1.0, 2, 4, 8, 16, 32, and 64 nM) at 5.0 mM Fe(CN)63−/4− solution (0.1 M PBS, pH 7.4). (B) The linear-linear and (C) linear-logarithmic calibration curve plots. (D) The plot of the Langmuir binding isotherm model. The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude voltage was 10 mV, DC voltage was 0.13 V, and the frequency range was 100 kHz–0.1 Hz. The error bars were obtained by using four different aptasensors.
Biosensors 12 00142 g004
Figure 5. (A) EIS of the CSPE/CNF–AuNP/Aptamer to 2 nM SARS-CoV-2 RBD in the absence (black curve) and presence of 200 nM of HIgG, HIgA, HIgM, and HSA (red curve). (B) The EIS of the CSPE/CNF–AuNP/Aptamer to 2 nM of SARS-CoV-2 RBD in the absence (red curve) and presence of 200 nM of HA, and N from an influenza A virus (blue curve). (C) The stability of the CSPE/CNF–AuNP/Aptamer on the different days (First day: green curve; Seventh day: black curve; Fourteenth day: red curve). EIS spectrums were recorded in 5.0 mM Fe(CN)63−/4− solution (0.1M PBS, pH 7.4). The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: Charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude was 10 mV, DC potential was 0.13 V, and the frequency range was 100 kHz−0.1 Hz.
Figure 5. (A) EIS of the CSPE/CNF–AuNP/Aptamer to 2 nM SARS-CoV-2 RBD in the absence (black curve) and presence of 200 nM of HIgG, HIgA, HIgM, and HSA (red curve). (B) The EIS of the CSPE/CNF–AuNP/Aptamer to 2 nM of SARS-CoV-2 RBD in the absence (red curve) and presence of 200 nM of HA, and N from an influenza A virus (blue curve). (C) The stability of the CSPE/CNF–AuNP/Aptamer on the different days (First day: green curve; Seventh day: black curve; Fourteenth day: red curve). EIS spectrums were recorded in 5.0 mM Fe(CN)63−/4− solution (0.1M PBS, pH 7.4). The equivalent electric circuit is compatible with the Nyquist diagrams. Rs: Solution resistance; Rct: Charge transfer resistance; Cdl: Double layer capacitance; Zw: Warburg impedance. The AC amplitude was 10 mV, DC potential was 0.13 V, and the frequency range was 100 kHz−0.1 Hz.
Biosensors 12 00142 g005
Table 1. Comparison of the analytical performance of the CSPE/CNF–AuNP/Aptamer with the other aptasensors and immunosensors for the biomarkers related to SARS-CoV-2.
Table 1. Comparison of the analytical performance of the CSPE/CNF–AuNP/Aptamer with the other aptasensors and immunosensors for the biomarkers related to SARS-CoV-2.
BiosensorBiomarkerMethodLinear RangeLimit of DetectionResponse TimeRef.
Carbon electrode/Graphene oxide/SP RBDSP (78.3 kDa)SWV1–1000 ng/mL0.11 ng/mL45 min[44]
CB/CSPE combined with Magnetic bead-based immunosensor2019-nCoV-NP (51.1 kDa)DPV0.19–11.7 nM
(0.01–0.6 μg/mL)
0.15 nM
(8 ng/mL)
30 min[11]
SP (78.3 kDa)DPV0.04–10 μg/mL19 ng/mL30 min
Gold electrode/Aptamer combined with a labeled aptamer2019-nCoV-NP (51.1 kDa)DPV0.00048–0.97 nM
(0.025–50 ng/mL)
(0.0048–0.97 nM)
0.00016 nM (8.33 pg/mL)60 min[23]
Pad/Aptamer2019-nCoV-NP (51.1 kDa)SPR0.5–16 ng/mL1 ng/mL (20 pM)110 min[21]
ITO/gC3N4-CdS/Chitosan-AptamerSARS-CoV-2-RBD (35 kDa)PEC0.5–32 nM
17.5–1120 nM
0.12 nM
4.2 ng/mL
40 min[18]
CSPE/Graphene/Spike IgG antibody 0.25 fg/mL–1 ng/mL0.25 fg/mL5[12]
CSPE/CNF–AuNP/AptamerSARS-CoV-2-RBD (35 KDa)EIS0.01–64 nM
(0.35–2240 ng/mL)
0.007 nM
(0.24 ng/mL)
40 minThis work
SP: Spike protein; CB/CSPE: Carbon black-modified screen-printed electrode; ITO: Indium Tin Oxide electrode;g-C3N4: Graphitic carbon nitride; CdS: Cadmium sulfide; PEC: Photo electrochemical method; SPR: Surface plasmon resonance; SWV: Square-wave voltammetry; 2019-nCoV-NP: SARS-CoV-2 nucleocapsid protein; DPV: Differential pulse voltammetry.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Amouzadeh Tabrizi, M.; Acedo, P. An Electrochemical Impedance Spectroscopy-Based Aptasensor for the Determination of SARS-CoV-2-RBD Using a Carbon Nanofiber–Gold Nanocomposite Modified Screen-Printed Electrode. Biosensors 2022, 12, 142. https://doi.org/10.3390/bios12030142

AMA Style

Amouzadeh Tabrizi M, Acedo P. An Electrochemical Impedance Spectroscopy-Based Aptasensor for the Determination of SARS-CoV-2-RBD Using a Carbon Nanofiber–Gold Nanocomposite Modified Screen-Printed Electrode. Biosensors. 2022; 12(3):142. https://doi.org/10.3390/bios12030142

Chicago/Turabian Style

Amouzadeh Tabrizi, Mahmoud, and Pablo Acedo. 2022. "An Electrochemical Impedance Spectroscopy-Based Aptasensor for the Determination of SARS-CoV-2-RBD Using a Carbon Nanofiber–Gold Nanocomposite Modified Screen-Printed Electrode" Biosensors 12, no. 3: 142. https://doi.org/10.3390/bios12030142

APA Style

Amouzadeh Tabrizi, M., & Acedo, P. (2022). An Electrochemical Impedance Spectroscopy-Based Aptasensor for the Determination of SARS-CoV-2-RBD Using a Carbon Nanofiber–Gold Nanocomposite Modified Screen-Printed Electrode. Biosensors, 12(3), 142. https://doi.org/10.3390/bios12030142

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop